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Neurons in the arcuate nucleus that produce AgRP,
NPY, and GABA (AgRP neurons) promote feeding.
Ablation of AgRP neurons in adult mice results in
Fos activation in postsynaptic neurons and starva-
tion. Loss of GABA is implicated in starvation
because chronic subcutaneous delivery of bretazenil
(a GABAA receptor partial agonist) suppresses Fos
activation and maintains feeding during ablation of
AgRP neurons. Moreover, under these conditions,
direct delivery of bretazenil into the parabrachial
nucleus (PBN), a direct target of AgRP neurons that
also relays gustatory and visceral sensory informa-
tion, is sufficient to maintain feeding. Conversely,
inactivation of GABA biosynthesis in the ARC or
blockade of GABAA receptors in the PBN of mice
promote anorexia. We suggest that activation of the
PBN by AgRP neuron ablation or gastrointestinal
malaise inhibits feeding. Chronic delivery of bretaze-
nil during loss of AgRP neurons provides time to
establish compensatory mechanisms that eventually
allow mice to eat.
INTRODUCTION
The agouti-related peptide (AgRP)-expressing neurons and the
neighboring pro-opiomelanocortin (POMC) -expressing neurons
that reside in the arcuate region of the hypothalamus integrate
hormonal and neurotransmitter signals to modulate appetite
and metabolism and thereby help maintain energy balance
(Cone, 2005; Morton et al., 2006; Saper et al., 2002). Genetic,
pharmacological, and physiological data establish that enhanced
melanocortin signaling by POMC neurons inhibits feeding
while stimulating metabolism (Cone, 2005). AgRP neurons, which
also produce neuropeptide Y (NPY) and g-amino-butyric acid
(GABA), send axons to many of the same brain regions as
POMC neurons, where they antagonize the effects of melanocor-
tin on postsynaptic cells (Broberger et al., 1998; Haskell-Luevano
et al., 1999; Jacobowitz and O’Donohue, 1978; Watson et al.,
1978).The literature on regulation of body weight has emphasized
the role of peptide hormones, neuropeptides, and monoamines
that act on membrane receptors to activate intracellular
signaling cascades (Cone, 2005; Morton et al., 2006; Saper
et al., 2002), with relatively little discussion of the role of neuro-
transmitters that regulate ion channels (Meister, 2007), despite
the fact that both GABAA and GABAB receptor agonists
enhance feeding by rodents and other animals (Cooper, 2005;
Duke et al., 2006; Ebenezer and Prabhaker, 2007). Research
on AgRP neurons was first directed toward the role of NPY
and then, after the discovery of AgRP and its coexpression
with NPY, focus turned to the complementary roles of these
neuropeptides in regulation of feeding behavior (Broberger
and Hokfelt, 2001; Flier, 2006; Kalra et al., 1999; Shutter
et al., 1997). However, inactivation of the genes encoding
NPY, AgRP, or both had little effect on body weight regulation,
suggesting that something else produced by these neurons
was important (Erickson et al., 1996; Qian et al., 2002). Support
for this idea came from experiments in which the AgRP neurons
were genetically engineered to express the diphtheria toxin
receptor (DTR), which allows their ablation by administration
of diphtheria toxin (DT). Ablation of AgRP neurons in adult
mice inhibits feeding and results in starvation within about
6 days of DT treatment (Gropp et al., 2005; Luquet et al.,
2005), even in mice lacking functional Npy and Agrp genes
(Phillips and Palmiter, 2008). Thus, the sudden loss of some-
thing other than NPY and AgRP promotes anorexia in this
model. The starvation phenotype following AgRP neuron
ablation is unaltered in the Ay genetic background, in which
melanocortin signaling is blocked by ectopic production of
agouti protein, indicating that starvation does not depend on
activation of the melanocortin-signaling pathway (Wu et al.,
2008a). Because AgRP neurons also express GABA (Cowley
et al., 2001; Horvath et al., 1997), these observations led to
the idea that GABA might be the critical transmitter produced
by AgRP neurons. Support for this hypothesis comes from
experiments in which GABA signaling by AgRP neurons was
prevented by selective inactivation of the vesicular GABA trans-
porter gene (Vgat); mice with constitutive inactivation of Vgat
had a lean phenotype and were resistance to diet-induced
obesity (Tong et al., 2008). This phenotype is reminiscent of
the mild phenotype observed after ablation of AgRP neurons
in neonatal mice (Luquet et al., 2005; Luquet et al., 2007),Cell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc. 1225
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Figure 1. Chronic Administration of Bretazenil Protects against Starvation in Adult Mice after Acute Ablation of AgRP Neurons
(A) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice after subcutaneous implantation of minipump (mp) loaded with either bretazenil
(n = 12) or vehicle (n = 10). DT was injected intramuscularly (im) twice as indicated by arrows. Minipumps were removed on day 11 after drug solution was
depleted.
(B) Liquid diet intake by the mice described in (A).
(C) Licking activity of the mice described in (A) was plotted as average number of licks in 2 hr bins.
Error bars represent the standard error of the mean (SEM). *p < 0.01, ANOVA.suggesting that compensation can occur when GABA
production by AgRP neurons is compromised during early
development.
As an alternative approach to examining the role of GABA
signaling from AgRP neurons, we tested the ability of GABAA
receptor agonists to maintain feeding after ablation of AgRP
neurons. An extensive literature indicates that benzodiazepines
can stimulate feeding and modulate taste reactivity—the stereo-
typed behaviors associated with different tastes (Berridge and
Pecina, 1995; Cooper, 2005). Experiments in rats identified
bretazenil as being particularly effective, in part, because it has
less sedative activity than first-generation benzodiazepines
such as diazepam. Benzodiazepines were the most effective for
modulating feeding when they were delivered into the fourth
ventricle. Direct injection into various hindbrain regions indicated
that the parabrachial nucleus (PBN) was an important site of
action in mediating taste reactivity (Higgs and Cooper, 1996).
The role of GABA in the hindbrain is particularly intriguing because
ablation of AgRP neurons in adult mice not only reduces the
motivation to initiate meals but also blocks consumption of liquid
food delivered directly into the mouth (Wu et al., 2008a), and the
latter is regulated by the hindbrain (Grill and Kaplan, 2002).
We previously demonstrated robust Fos gene activation in
numerous postsynaptic targets of AgRP neurons following abla-
tion of AgRP neurons (Wu et al., 2008a, 2008b). These findings1226 Cell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc.suggested that lack of GABA signaling from AgRP neurons could
lead to hyperactivity in postsynaptic targets. The resulting dysre-
gulation caused by lack of GABA signaling from AgRP neurons
could be responsible for the blockade of both appetitive and
consummatory aspects of feeding (Wu et al., 2008a). Here we
show that chronic stimulation of GABAergic signaling within
a specific brain region allows feeding to continue after AgRP
neuron ablation and adaptations that eventually allow mice to
eat without AgRP neurons.
RESULTS
Suppression of Anorexia following Ablation of AgRP
Neurons by Chronic Delivery of a GABAA
Receptor Agonist
Mice in which the human DTR was targeted to the Agrp locus
(AgrpDTR/+) were used for these studies. In agreement with
previous results (Luquet et al., 2005; Wu et al., 2008a), adminis-
tration of DT to these mice (2 intramuscular injections, 50 mg/kg,
2 days apart) results in progressive decline in food intake such
that body weight falls 20% by 6–7 days, at which point the
experiments are terminated for animal welfare considerations
and to collect brain tissues for analysis (Figures 1A and 1B).
We showed previously that ablation of AgRP neurons by this
method results in robust induction of Fos mRNA in most
postsynaptic targets of AgRP neurons and speculated that aber-
rant excitation of postsynaptic neurons could be responsible for
the starvation phenotype (Wu et al., 2008a). To test this idea,
Alzet minipumps were loaded with bretazenil, a GABAA receptor
partial agonist, and were implanted subcutaneously to deliver
750 ng/hr for 14 days. After 3 baseline days with the bretaze-
nil-eluting minipump, the AgrpDTR/+ mice were treated with DT
as before. In contrast to starvation normally observed, mice
with the minipump transiently lost <10% of their body weight,
and their body weight returned to normal. Food consumption
by the bretazenil-treated group fell for the first 6 days after DT
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Figure 2. MinipumpDelivery of Bretazenil into the Fourth Ventricle Is
More Efficacious than Delivery into the Third Ventricle
(A) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice in which
bretazenil (75 ng/hr; 1/10 of the dosage used in Figure 1) or vehicle was chron-
ically administered either subcutaneously (sc) or directly into the third (3v) or
fourth (4v) ventricle.
(B) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice in
which bretazenil (15 ng/hr; 1/50 of the dosage used in Figure 1) or vehicle
was chronically administered directly into the third or fourth ventricle. Note
that abrupt withdrawal of bretazenil delivered into the fourth ventricle at day
4 resulted in more profound decline of body weight than that was shown by
the AgRP-ablated mice infused with vehicle; *p < 0.01, ANOVA.
(C) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice in which
bretazenil (7.5 or 2.5 ng/hr, 1/100 or 1/300 of the dosage used in Figure 1,
respectively) or vehicle was chronically administered directly into either the
third or fourth ventricle.
n = 6–8 for each group. Error bars represent the SEM.treatment, but then also returned to normal over the next
12 days (Figures 1A and 1B). Remarkably, feeding continued
even when the minipump was removed 11 days after initiation
of DT treatment (Figures 1A and 1B). Licking activity at the liquid
food dispenser persisted with a typical daily rhythm in the breta-
zenil-treated group, whereas, in the absence of the agonist,
licking ceased 7 days after DT treatment began (Figure 1C).
Bretazenil (0.2 mg/kg, i.p.) increased food consumption by
wild-type mice during the first 4 hr, but 24 hr food intake was
normal. Chronic delivery of bretazenil to wild-type animals for
10 days via a minipump had no effect on body weight (see
Figure S1 available online). Once-daily administration of bretaze-
nil (0.2 mg/kg, i.p.) was ineffective at preventing starvation after
AgRP neuron ablation, suggesting that chronic activation of
GABAA receptors is an important aspect of the rescue strategy
(Figure S2).
The number of meals was maintained by mice with the bretaze-
nil-eluting minipump after ablation, whereas it gradually declined
to nothing without drug treatment (Figure S3A). The meal size
(number of licks per meal) persisted at a comparable level
throughout the time course in bretazenil-treated group (Fig-
ure S3B) instead of increasing as expected for food-deprived
animals (Wu et al., 2008a). Ablation of AgRP neurons also prevents
normal food consumption even when food is delivered directly
into the mouth via an intraoral fistula, indicating that consumma-
tory aspects of feeding are also disrupted (Wu et al., 2008a).
Chronic treatment with bretazenil restored intra-oral sucrose
consumption to >80% of original after ablation of AgRP neurons
(Figure S3C). Thus, both consummatory and appetitive responses
are rescued by bretazenil treatment after AgRP neuron ablation.
Enhanced GABAA Receptor Signaling in Hindbrain
Rescues Feeding after Ablation of AgRP Neurons
To grossly determine where in the brain GABAA receptor activa-
tion is most important for maintenance of feeding, Alzet
minipumps were implanted subcutaneously and connected to
cannulas placed into either the third or fourth ventricles. When
bretazenil was delivered at 75 ng/hr into the fourth ventricle or
subcutaneously, it rescued feeding after AgRP neuron ablation;
delivery of this dose into the third ventricle retarded weight
loss but did not prevent starvation (Figure 2A). Mice with delivery
of bretazenil into the third ventricle appeared sedated, which
may have prevented adequate feeding. To minimize the sedative
effects, the dose was reduced another 5 fold. Delivery of breta-
zenil (15 ng/hr) into either third or fourth ventricle was sufficient to
prevent starvation (Figure 2B), and sedation was no longer
apparent. Delivery of bretazenil into the fourth ventricle at an
even lower dose (7.5 ng/hr) still maintained body weight within
acceptable limits; however, delivery of this dose into the third
ventricle delayed loss of body weight to 80% of original body
weight (Figure 2C). A further 3-fold reduction of bretazenil
delivery (2.5 ng/hr) was ineffective at preventing weight loss in
the AgRP-ablated mice (Figure 2C). These results indicate that
delivery of an appropriate dose of bretazenil into either the third
or fourth ventricle can maintain adequate feeding, but the effect
of the drug in the brainstem is marginally more effective than in
the forebrain. Daily administration of bretazenil into the fourth
ventricle (1 mg/day) significantly slowed the starvation phenotypeCell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc. 1227
but was unable to prevent it, again suggesting that chronic
delivery of the drug is critical (Figure S4). It is noteworthy that
withdrawal of the minipump delivering bretazenil at 75 ng/hr
into the fourth ventricle at day 4 after initiation of DT treatment
resulted in precipitous loss of body weight (Figure 2B), whereas
the mice continued to feed when the minipumps were removed
at day 11 (Figures 1A and 1B).
To confirm that the action of bretazenil is mediated by GABAA
receptors, we blocked the effect of bretazenil with flumazenil,
a GABAA receptor antagonist. Mice with minipumps delivering
bretazenil (750 ng/hr, s.c.) were treated with DT as above, but
then flumazenil was introduced either peripherally (10 mg/kg,
i.p.) or into the third or fourth ventricle (3 mg) on a once-daily
basis. Mice receiving either peripheral or the fourth ventricle
delivery of the antagonist stopped feeding and rapidly lost
body weight during the next 3 or 4 days, whereas mice with
delivery of the flumazenil into the third ventricle survived (Figures
S5A and S5B). Dispensing the same dose of flumazenil into the
fourth ventricle of DT-treated, wild-type mice had no effect on
food intake or body weight, as expected, since this drug only
blocks the benzodiazepine site (Figures S5A and S5B). These
results help establish the GABAA receptor as the critical target
of bretazenil and suggest that GABA signaling in the brainstem
is more important than in the forebrain for maintenance of
feeding behavior in AgRP-ablated mice.
Activation of GABAA Receptors Suppresses
Fos and Astrocyte Activity
Ablation of AgRP neurons leads to robust induction of FosmRNA
in many brain regions that are known postsynaptic targets of
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Figure 3. Fos Activation after AgRP Neuron Ablation Is
Suppressed in Some Brain Regions by Bretazenil Treat-
ment
(A–E) Representative pictures of Fos in situ hybridization in post-
synaptic regions of AgRP neurons including the ARC (A), PVN
(B), LS (C), PBN (D), and NTS (E), in pair-fed AgrpDTR/+ mice after
losing 20% of their initial body weight. Postsynaptic areas of
AgRP neurons are denoted by dotted lines.
(F–J) Representative pictures of Fos in situ hybridization in the
same postsynaptic regions of AgRP neurons in DT-treated,
AgrpDTR/+ mice after losing 20% of their initial body weight.
(L–P) Representative pictures of Fos in situ hybridization in the
same postsynaptic regions of AgRP neurons in DT-treated,
AgrpDTR/+ mice with subcutaneous implantation of minipumps
eluting bretazenil.
(Q) Quantified results for Fos in situ signals in selected postsyn-
aptic regions of AgRP neurons of either pair-fed, DT-treated, or
DT/bretazenil-treated, AgrpDTR/+ mice. See Figure S6 for a com-
plete set of images of Fos in situ hybridization in these regions.
*p < 0.01 between the DT-treated group and the DT/bretazenil-
treated group for each respective area, ANOVA.
n = 4–6 per group. Scale bar (in A): A–C, F–H, and L–N, 400 mm;
scale bar (in D): D, E, I, J, O, and P, 400 mm. Error bars in (Q) repre-
sent the SEM.
AgRP neurons, compared to pair-fed, control mice
(Wu et al., 2008b). We hypothesized that the inhibition
of feeding after ablation of AgRP neurons is due to
the dysregulation of critical feeding circuits and that
bretazenil acts by reducing neuronal activation. Hence, we
measured Fos gene activation by semiautomated in situ hybrid-
ization (Lein et al., 2007). Bretazenil (minipump at 750 ng/hr, s.c.)
significantly reduced Fos expression in 5 of the 8 brain regions
that are heavily innervated by AgRP fibers (Figures 3 and S6).
In the forebrain, Fos expression was reduced in the arcuate
nucleus (ARC), paraventricular nucleus (PVN), and the lateral
septum (LS), while in the hindbrain the reduction was striking in
the PBN and nucleus of the solitary tract (NTS). The LS and
PBN were the only anatomic positions where Fos expression
was reduced to the level observed in pair-fed mice (summarized
in Figure 3Q). Delivery of bretazenil (75 ng/hr) into the
third ventricle suppressed Fos and astrocyte activation in the
ARC and PVN but not in the PBN, whereas delivery of bretazenil
into the fourth ventricle suppressed Fos activation in the PBN
but not the ARC or PVN, indicating that appreciable amounts
of the drug do not diffuse from one ventricle to another
(Figure S7).
Ablation of AgRP neurons not only induces Fos expression in
postsynaptic brain regions but also activates astrocytes and
microglia in most of the same regions (Wu et al., 2008b). Release
of cytokines and other molecules by activated glia may contribute
to the dysregulation of feeding. We found that chronic treatment
with bretazenil suppressed activation of astrocytes (revealed by
GFAP immunohistochemistry) without reducing microglial activa-
tion (revealed by IBA1 immunohistochemistry) in most postsyn-
aptic targets of AgRP neurons (Figure S8). Moreover, like the
effects on Fos activation, the suppression of astrocyte activation
was restricted to the brain regions in proximity to the ventricle
where bretazenil was delivered (Figure S8).
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GABAA Receptor Signaling to the PBN Is Necessary
to Prevent Anorexia
On the basis of the observation that Fos expression was reduced
in 5 of the brain regions examined, we attempted to rescue
feeding by minipump delivery of bretazenil (15 ng/hr) bilaterally
into those selected brain regions. In the hindbrain, only delivery
of bretazenil into the PBN achieved a full recovery of body weight
following a transient loss of 10% during the time course of
treatment; whereas delivery into the PAG or NTS was ineffective
(Figure 4A). In the forebrain, delivery of bretazenil to the PVN was
ineffective; however, delivery into the LS prolonged survival
about 1 week, but the mice eventually lost 80% of their body
weight (Figure 4B). These results indicate that stimulating
GABAergic signaling in the PBN is sufficient to protect against
starvation in AgRP neuron-ablated mice.
The coordinates for bretazenil infusion into the PBN are shown
in Figure 4C. In those cases where the cannulas were misplaced
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Figure 4. Administration of Bretazenil into the PBN Prevents Starva-
tion in Mice after Ablation of AgRP Neurons
(A) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice after
chronic administration of bretazenil in 3 postsynaptic areas of AgRP neurons
in the hindbrain (PBN, PAG, and NTS).
(B) Percentage of initial body weight of DT-treated, AgrpDTR/+ mice after
chronic administration of bretazenil in 2 forebrain regions (PVN and LS) with
projections from AgRP neurons.
n = 6–8 per each group. Error bars represent the SEM.
(C) Coronal illustrations of mouse hindbrain regions; the dots represent
effective infusion sites in the PBN area. LC, locus ceruleus; 4v, fourth ventricle.or one or both sides became clogged, anorexia was not pre-
vented by bretazenil. The observation that delivery of bretazenil
to the PAG was ineffective at preventing anorexia indicates that
the effective diffusion range of bretazenil is less than 1.2 mm (the
average distance from PAG to PBN). Likewise, delivery of breta-
zenil to the PBN suppressed Fos expression in the PBN but not in
neighboring nuclei where Fos is activated after AgRP neuron
ablation (data not shown).
To determine whether inhibition of GABAA-receptor signaling
would lead to anorexia in normal mice, bicuculline, an antagonist
that binds to the GABA site in the receptor, was infused into the
PBN via bilateral cannulas for 4 days, and then the pumps were
disconnected. There was a dose-dependent inhibition of feeding
and loss of body weight that rebounded when drug delivery
ceased (Figures 5A and 5B). Thus, continual GABA signaling in
the PBN is necessary to maintain feeding behavior and prevent
anorexia.
To establish whether signaling from AgRP neurons to the PBN
is required to maintain feeding, DT was injected into the PBN
with the assumption the human DTR would be located
throughout AgRP neurons, including their axons; thus, engaging
DTR receptors on axonal processes would mediate cell death.
Figures 5C and 5D show that AgrpDTR mice injected bilaterally
with a low dose of DT (4 ng per side) became anorexic, whereas
injection of control mice with DT had no effect. Injection of the
same dose of DT bilaterally into the LS did not lead to anorexia
(data not shown).
AgRP Neurons in the ARC Are GABAergic
The in situ hybridization experiments included probes for Agrp
and Gad1 mRNA. Gad1 encodes glutamate decarboxylase
(GAD67), the major biosynthetic enzyme for GABA. Figure S9
reveals nearly complete loss of Agrp hybridization signal in the
ARC of mice treated with DT, regardless of whether they had
a bretazenil-eluting minipump. Thus, the rescue from starvation
by bretazenil is not due to protection of AgRP neurons from
DT-mediated ablation. Ablation of AgRP neurons with DT treat-
ment resulted in 65% depletion of Gad1 mRNA in the ARC,
but not in the dorsomedial hypothalamus (Figures 6A–6D) indi-
cating that AgRP neurons are the predominant population of
GABAergic cells in the ARC.
Inactivation of the Gad1 Gene in the ARC of Adult Mice
Produces Anorexia
The previous results suggest that loss of GABAA-receptor
signaling within the PBN contributes to the severe anorexia
observed after ablation of AgRP neurons. To examine whether
the loss of GABA signaling from the ARC to the PBN is directly
involved, we used an adeno-associated virus (AAV) strategy to
inactivate GABA synthesis in the ARC. Mice with conditional
Gad1 alleles (Gad1lox/lox), null alleles of Gad2 (Gad2/), and
flox-stop Rosa26 reporter allele (G(t)RosafsLacZ/fsLacZ) were in-
jected bilaterally in the ARC with AAV1-CreGFP. When the
Cre-expressing virus was delivered precisely to the ARC, as
shown in Figure 6E (4 of 16 injected mice), food intake began
to decline 5 days after viral injection and body weight fell
significantly below the preinjection weight, but the mice survived
at least 23 days (Figures 6H and 6I). However, when viralCell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc. 1229
transduction was either unilateral in the ARC, in more dorsal
regions of the hypothalamus, or undetectable (12 of 16 injected
mice) there was no effect on feeding behavior (Figures 6F–6I).
These results indicate that the inhibition of feeding is not an
indirect consequence of viral delivery, but GABA synthesis by
neurons that reside in the ARC is important for maintenance of
feeding behavior.
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Figure 6. Loss of GABAergic Signaling by
AgRP Neurons Promotes Anorexia
(A–C) Representative pictures of Gad1 in situ hy-
bridization in the ARC ofAgrpDTR/+mice after either
pair feeding (A), DT treatment (B), or DT treatment
plus chronic administration of bretazenil (C).
(D) Quantified results for Gad1 in situ signals in the
ARC of the mice described in (A)–(C). *p < 0.01,
ANOVA. Error bars represent the SEM.
n = 6 mice per each group. Scale bar (in A): A–C,
400 mm.
(E–G) Representative pictures of GFP immunos-
taining showing the AAV1-Cre-GFP infected
neurons located either precisely in the ARC (n =
4; E) or at nonspecific surrounding areas (F) or
completely absent from region (G) (n = 12) in
Gad1lox/lox, Gad2/, Rosa26fsLacZ/fsLacZ mice.
Scale bar (in E): E–G, 400 mm.
(H and I) Percentage change of body weight and
intake of liquid diet by the mice with infection in
the ARC (E) or missed (F and G). Statistical signif-
icance (*p < 0.01, ANOVA) was obtained starting
from day 6 until end of the experiment. Error
bars represent the SEM.
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Figure 5. Inhibition of GABAA Receptors in
the PBN or Disruption of the Neural Inputs
from AgRP Neurons to the PBN Produces
Anorexia
(A) Percentage of initial body weight of C57BL/6
wild-type mice in which bicuculline (100, 300,
and 1000 ng/day) was chronically infused to the
PBN area through bilateral cannulae for 4 days
and then discontinued.
(B) Intake of liquid diet by the mice described in (A).
*p < 0.01, ANOVA between the groups of 100 ng/
day and 1000 ng/day. Error bars represent the
SEM. n = 5–6 mice per group.
(C) Percentage of initial body weight of AgrpDTR/+
and wild-type mice that received a single injection
of DT into the PBN area (bilateral, 4 ng per side).
(D) Intake of liquid diet by the mice described in (C).
AgRP Neurons May Directly
Innervate the Fos-Positive
Cells in the PBN
Broberger et al. (1998) established that
the PBN is a prominent postsynaptic
target of NPY fibers from hypothalamic
NPY/AgRP neurons, on the basis of
showing that all of the fiber staining was eliminated after destroy-
ing neurons in the ARC with monosodium glutamate treatment.
To ascertain whether the Fos-positive cells in the PBN that arise
after ablation of AgRP neurons are possibly direct targets of
AgRP neurons, we stained sections including the PBN with anti-
sera against Fos and NPY. This experiment was performed
4 days after the initial DT treatment, at a time when Fos was
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already activated but the AgRP/NPY neurons had not yet degen-
erated. Figures S10A and S10D–S10F show that Fos-positive
cells are in close proximity to NPY fibers, which supports the
possibility that activation of Fos may be due to direct loss of
GABA signaling from AgRP neurons onto select PBN neurons.
The Fos-positive cells are in the lateral segment of the PBN, in
the same region where Fos is activated by peritoneal injection
of LiCl, a treatment that produces gastrointestinal malaise
(Figures S10B and S10C).We have also observed a large,
progressive increase of GAD67 staining in fibers throughout
the PBN during the 6 days after treatment of AgrpDTR mice
with DT that could reflect a compensatory increase by other
GABAergic neurons (Figures S10G–S10I).
DISCUSSION
Our results establish the importance of GABA signaling by AgRP
neurons onto postsynaptic GABAA receptors for maintenance of
feeding behavior. Two lines of evidence support this conclusion:
starvation resulting from AgRP neuron ablation can be prevented
by chronic delivery of a GABAA receptor agonist, and viral-medi-
ated inactivation of GABA biosynthesis in the ARC inhibits
feeding. Furthermore, ablation of AgRP neurons in mice lacking
AgRP and NPY, the other known neuromodulators made by
these neurons, results in starvation; hence, loss of these neuro-
peptides is not responsible for the starvation phenotype (Phillips
and Palmiter, 2008).
We suggest that loss of GABA signaling from AgRP neurons
onto postsynaptic GABAA receptors results in unopposed exci-
tation of postsynaptic cells as revealed by Fos and astrocyte
activation. Our observation that inactivation of GABA synthesis
in the ARC leads to anorexia suggests that direct GABA signaling
by AgRP neurons to critical brain regions is important to maintain
feeding after AgRP neuron ablation; however, we cannot rule out
the contribution by other neurons in the ARC that produce GABA
such as the POMC neurons (Hentges et al., 2004). The anorexia
observed with viral inactivation of GABA synthesis was more
severe than that observed by Tong et al. (2008) but still not as
great as that observed with AgRP neuron ablation, presumably
because only a fraction of the AgRP neurons was transduced
by the virus.
We assume that chronic delivery of bretazenil during AgRP
neuron ablation provides sufficient inhibitory tone to suppress
the excitability of postsynaptic cells in critical feeding circuits,
but suppression of cytokine production by astrocytes may also
be involved. We predicted that those brain regions where Fos
mRNA was lowered the most would reveal the most critical brain
regions. We have identified two brain targets of AgRP neurons
(PBN and LS) that appear to be particularly important. The
most dramatic reduction of Fos expression was in the PBN, which
is the only brain region where direct delivery of bretazenil was
able to prevent starvation, although delivery of bretazenil to the
LS was partially effective. Furthermore, injection of DT into the
PBN (but not the LS) produced anorexia, indicating that signaling
by AgRP neurons to this brain region is particularly important.
Nevertheless, experiments involving chronic delivery of bretaze-
nil to the third or fourth ventricle suggest that excessive neuronal
activity in both forebrain and hindbrain may contribute to theeating disorder. The pharmacology of the agonists and antago-
nists used in this study indicate that GABA signaling from AgRP
neurons onto GABAA receptors is sufficient to prevent starvation,
but activation of GABAB receptors may also be involved.
The close apposition of axonal fibers from AgRP neurons with
Fos-positive neurons in the lateral PBN suggests that there
may be direct GABA signaling onto the critical PBN neurons.
The PBN is a major relay for gustatory and visceral information
and mediates anorexia associated with malaise induced by intra-
peritoneal injection of LiCl or lipopolysaccharide—treatments
that are used to mimic the effects of toxic or rancid foods and
bacterial infections, respectively (Rinaman and Dzmura, 2007).
Lesions of PBN prevent the acquisition of conditioned taste
aversion (Trifunovic and Reilly, 2002) and conditioned taste
preferences (Reilly and Trifunovic, 2000). The PBN is the most
responsive brain region where benzodiazepine injection
promotes taste reactivity (Berridge and Pecina, 1995). Direct
injections of cannabinoid or mu-opioid receptor agonists into
the PBN stimulate feeding (Chaijale et al., 2008; DiPatrizio and
Simansky, 2008; Wilson et al., 2003). Thus, the PBN can process
both aversive and appetitive ascending visceral information to
modulate feeding behavior. LiCl-induced anorexia induces
robust Fos expression in the PBN and other brain regions (Andre
et al., 2007; Lamprecht and Dudai, 1995; Swank and Bernstein,
1994). The Fos-positive cells in the PBN after LiCl induction are in
the same region of the PBN as those induced after AgRP neuron
ablation. Thus, it is likely that loss of GABAergic input to the PBN
after AgRP neuron ablation activates circuits that normally
promote nausea-induced anorexia. Our findings that bretazenil
infusion into the PBN prevents anorexia induced by AgRP
neuron ablation, while infusion of bicuculline into the PBN of
normal mice promotes anorexia, are consistent with this hypoth-
esis. The role played by the LS in feeding is more obscure.
Because the LS relays signals related to sensory input and
reward and projects to the lateral hypothalamus with a well-
established role in feeding behavior (Bernardis and Bellinger,
1996), aberrant activity within the LS may produce anorexia via
its projections to the lateral hypothalamus. Pharmacological,
electrophysiological, and lesion experiments suggest a role of
the LS in modulation of feeding (Scopinho et al., 2008), but the
precise role of the GABAergic inputs from AgRP neurons to
this brain region requires further investigation.
In addition to the consensus view that AgRP neurons oppose
melanocortin signaling by POMC neurons in pathways that regu-
late appetite and metabolism (Cone, 2005; Morton et al., 2006;
Saper et al., 2002), we propose that there are some brain regions
such as the PBN where AgRP neurons have largely melanocor-
tin-independent effects. In our view (Figure 7), ablation (or inhibi-
tion) of AgRP neurons leads to activation of POMC neurons and
the melanocortin-signaling pathway, as well as a pathway
involving the PBN, both of which inhibit feeding. Activation of
AgRP neurons has the opposite effect. The profound anorexia
that ensues from activation of the PBN—perhaps mimicking
severe gastrointestinal malaise or aversive gustatory input—
could mask the role of AgRP neurons in regulating appetite
and metabolism by counteracting melanocortin signaling. The
transient10% loss of body weight that still occurs when breta-
zenil is infused may reflect the melancortin-dependent role ofCell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc. 1231
AgRP neurons on feeding and metabolism. If so, this effect is
gradually compensated because the mice eventually regain their
body weight after10 days, which may account for the relatively
mild effect of chronic loss of GABA signaling by AgRP neurons
(Tong et al., 2008).
It is noteworthy that abrupt withdrawal of bretazenil during
fourth ventricle delivery results in a more precipitous decline of
body weight than that achieved by ablation of AgRP neurons
alone. This result mimics the loss of body weight and appetite,
a common symptom of the ‘‘benzodiazepine withdrawal
syndrome’’ seen in patients who discontinue chronic use of
benzodiazepines (Pecknold, 1993). In parallel with a clinical study
showing that flumazenil treatment alleviated the withdrawal
syndrome (Gerra et al., 2002), our results demonstrate that
bretazenil-mediated restoration of food intake was completely
abolished by the fourth ventricle administration of flumazenil.
On the other hand, after cessation of chronic infusion of bicucul-
line into the PBN of wild-type mice, their anorexia switched to
prolonged hyperphagia that was inversely proportional to the
dosage of bicuculline. These complementary results illustrate
robust dynamics and sensitivity of a hindbrain GABA signaling
network that governs appetite and food palatability.
An unexpected finding is that feeding persists in AgRP neuron-
ablated mice after the bretazenil-eluting minipumps are depleted
or removed. This result is reminiscent of the observation that
ablation of AgRP neurons in neonatal mice does not result in
Figure 7. Diagram Illustrating How Loss of GABAergic Signaling
from AgRP Neurons Leads to Starvation
AgRP and POMC neurons that reside in the ARC send axons to many of the
same target areas (e.g., the PVN, MPO, PAG, NTS, and PBN). Ablation (or inhi-
bition) of inhibitory AgRP neurons leads to anorexia by two mechanisms. First,
the loss of inhibition onto POMC neurons and their postsynaptic target
cells stimulates the melanocortin system, which suppresses feeding. Second,
the loss of GABAergic inhibition onto neurons in the PBN (and to a lesser extent
the LS) mimics the activation of these neurons in response to gastrointestinal
malaise, resulting in severe anorexia, an effect that is independent of
melanocortin signaling. The severe anorexia can be prevented by infusing
bretazenil, a GABAA receptor partial agonist, into the PBN, which antagonizes
Fos activation.1232 Cell 137, 1225–1234, June 26, 2009 ª2009 Elsevier Inc.starvation (Luquet et al., 2005; Phillips and Palmiter, 2008). We
suggested previously (Luquet et al., 2005) that ablation of
AgRP neurons in neonates has a minimal effect on feeding
because adaptations can take place during the 2 to 3 weeks
between ablation and weaning, when AgRP neurons mature
and independent feeding becomes important (Nilsson et al.,
2005). We originally thought that the adaptations might involve
establishing new neuronal circuits, but the present results
suggest a different explanation. We now suggest that the hyper-
active postsynaptic neurons adapt by reducing the effects of
excitatory inputs and/or enhancing alternative inhibitory inputs
(Horvath, 2006). The increase in GAD67 staining in the PBN after
AgRP neuron ablation may reflect such compensatory changes.
Synaptic plasticity could also involve changes in the number of
excitatory and/or inhibitory synapses as well as changes in the
abundance and activity of various receptors, including ion
channels and G protein-coupled receptors. Examination of the
mechanisms involved will depend on more precise identification
of the postsynaptic neurons with elevated Fos signal. Our results
suggest that these hypothetical adaptations are incomplete and
mostly ineffective 6 days after DT treatment, but can be estab-
lished within 11 days with the aid of chronic GABAA-receptor
activation. In this view, bretazenil suppresses the excitability of
postsynaptic neurons and reduces local gliosis, which, in turn,
renders sufficient time and a favorable physiological setting for
the adaptations to occur.
EXPERIMENTAL PROCEDURES
Animal Maintenance and Neuron Ablation
Mice were housed in a temperature- and humidity-controlled facility with
a 12 hr light/dark cycle. All animal care and experimental procedures were
approved by the Institutional Animal Care and Use Committee at the University
of Washington. In compliance with our approved protocol, all experiments
were terminated if the body weight of mice fell to 80% of their original body
weight. AgrpDTR/+ mice were generated by targeting the human diphtheria
toxin receptor (heparin-binding epidermal growth factor) to the Agrp locus
(Luquet et al., 2005). Gad1lox/lox mice (with loxP sites flanking exon 2) were
generated as described elsewhere (Chattopadhyaya et al., 2007). They were
bred with Gad2/ mice (Kash et al., 1997) and Gt(ROSA)26SorfsLacZ/fsLacZ
mice (Soriano, 1999) to create the triple homozygotes that were used for viral
injection experiments. Mice were group housed with standard chow diet (Lab-
Diet 5053) and water provided ad libitum until the beginning of the experiments.
To ablate AgRP neurons in adult mice, intramuscular injection of diphtheria
toxin (two injections of 50 mg/kg, 2 days apart; List Biological Laboratories,
Campbell, CA, USA) in 6-week-old mice was performed (Luquet et al., 2005).
Viral Injections
AAV1 virus expressing myc-nls-Cre-GFP fusion protein was kindly provided by
James Allen (University of Washington). The virus was produced by transfect-
ing HEK cells and then purified from cell extracts by pelleting through sucrose
followed by banding on a CsCl gradient. Mice were anesthetized and virus was
injected bilaterally (1 ml of 109 particles/ml per each side) through a cannula-
guided injector (31 gauge, Plastics One, Roanoke, VA, USA) just above the
ARC using coordinates ± 0.5 mm (x axis), 1.4 mm (y axis), and 6 mm
(z axis) (Paxinos and Frank, 2001). Brain samples from all mice were collected
at the end of the experiment, and we proceeded with immunohistological
analysis.
In Situ Hybridization
Brains were sectioned (25 mm coronal), and every eighth section was used for
either Nissl staining or in situ hybridization with Agrp, Fos, or Gad1 using an
automated procedure for hybridization and image capture. Materials and
procedures concerning this high-throughput data generation process (ribop-
robe production, tissue processing, in situ hybridization, and image capture
and processing) have been described elsewhere (Lein et al., 2007) and are
available on the Allen Brain Atlas website (http://www.brain-map.org).
Drug Treatments
Alzet 14 day micro-osmotic pumps (model 1002, Durect, Cupertino, CA, USA)
loaded with 100 ml of bretazenil (3 mg/ml in saline plus 10% DMSO; Sigma-
Aldrich, St Louis, MO, USA) were implanted subcutaneously on the back of
anesthetized mice 3 days before DT treatment. These minipumps dispense
0.25 ml/hr. Alternatively, cannulas (28 gauge, Plastics One) were placed into
either the third or fourth ventricles under anesthesia, and the subcutaneous
Alzet minipumps were connected to the cannulas by tubing (PE60; Stoelting,
Wood Dale, IL, USA) that was threaded under the skin to help prevent the
mice from dislodging it. For some experiments, the Alzet minipumps were con-
nected to bilateral cannulas (28 gauge, Plastics One) directed to specific brain
regions by using the following coordinates: the PVN, ± 0.5 mm (x axis),
0.8 mm (y axis), and 4.6 mm (z axis); the LS, ± 0.5 mm (x axis), 0.3 mm
(y axis), and 3.8 mm (Z axis); the PBN, ± 1 mm (x axis), 5.3 mm (y axis),
and 3.3 mm (z axis); the PAG, ± 1 mm (x axis), 4.75 mm (y axis), and
2.8 mm (Z axis); and the NTS, ± 1 mm (x axis),7.4 mm (y axis), and4.5 mm
(z axis). Bretazenil used for central administration was prepared by diluting the
stock solution (3 mg/ml in DMSO) in saline as indicated in the text and figure
legends. For one experiment, the mice had a subcutaneous minipump loaded
with bretazenil (3 mg/ml), and then flumazenil, a GABAA receptor antagonist
(1.5 ml of 2 mg/ml in saline, Sigma-Aldrich), was injected either intraperitoneally
or into the third or fourth ventricle via a cannula-guided injector (31 gauge,
Plastics One) through a Hamilton syringe (size 25 ml, Hamilton, Reno, NV,
USA). Of note, flumazenil or vehicle was injected at 8:00 pm immediately
before the mice entered active feeding phase. Bicuculline methiodide
(a water-soluble form of bicuculline, Sigma-Aldrich) was prepared in saline
(170 mg/ml, 50 mg/ml, and 17 mg/ml) and loaded to Alzet mini pumps for central
infusion. LiCl (0.15 M in saline, J.T. Baker) was injected intraperitoneally at
a dose of 20 ml/g of body weight (0.12 g/kg), then after 24 hr, the brains
were collected and processed for immunohistochemistry. The patency and
placement of the bilateral minipump was verified at the end of each experiment
by infusing a blue dye followed by histological analysis.
Food Intake and Body Weight Measurements
For feeding assays, mice were transferred to lickometer cages (Columbus
Instruments, Columbus, OH, USA) supplied with water and liquid diet (5LD-
101, TestDiet, Richmond, IN, USA; 1 Kcal/ml). The mice were allowed to
acclimate for 3 days before initiating each experiment and data collection.
Body weight and total food intake were recorded every 24 hr. Licking activity
at food and water dispensers was recorded continuously, as described else-
where (Wu et al., 2008a). Licking data were grouped into 2 hr bins and further
analyzed by using a program encoded by the Python software.
Intra-Oral Feeding Studies
Intra-oral fistulas were implanted under anesthesia at the same time when
inserting minipumps loaded with bretazenil. Consumption of 0.1 M sucrose
solution was measured as described elsewhere (Wu et al., 2008a).
Immunohistochemistry
Mice were sacrificed by CO2 asphyxiation and perfused transcardially with ice-
cold PBS buffer containing 4% paraformaldehyde. Brains were dissected and
postfixed overnight at 4C in the fixation buffer. Free-floating brain sections
(30 mm) were washed in PBS and 0.1% Triton X-100 (PBST buffer) solution
3 3 15 min and then were blocked with 3% normal donkey serum in PBST
for 2–3 hr at room temperature. Rabbit anti-GFAP (1:3000 dilution; Novus Bio-
logicals), rabbit anti-IBA1 (1:1000 dilution; Wako Chemicals USA), guinea pig
anti-NPY (1:1000 dilution; Abcam), rabbit anti-Fos (1: 1500 dilution; Millipore),
and monoclonal anti-GAD67 (1:1000 dilution, Sigma) were applied to the
sections for overnight incubation at 4C, followed by 3 3 15 min rinses in
PBST. Finally, sections were incubated in Cy2- or Cy3-labeled secondary anti-
body (1:300 dilution, Jackson Immunolaboratory) before visualization. Imageswere captured using a digital camera mounted on a Leica TCS SP1 confocal
microscope (Leica Microsystems USA); all paired photos were obtained
through the same system setting. For each group of mice, at least 8 sections
from 4 different mice were analyzed.
Data Analyses
Quantification of Fos-positive cells was done using the NIH Image software
(National Institutes of Health). Anatomical correlations of brain sections and
delineation of individual nuclei were determined by comparing landmarks of
Nissl staining images with those given in the stereotaxic atlas (Paxinos and
Frank, 2001). From the anatomically matched sections, a region of interest
of the same size was further defined. Meanwhile, an optimized threshold
that can discern round Fos-positive nuclei from partially stained ones as well
as background noise was preset for all measurement. The total number of
pixels of Fos-positive cells inside the defined region was automatically re-
corded. Data sets collected from all experiments, unless otherwise stated,
were analyzed by one-way ANOVA followed by Student-Newman-Keuls
method for statistical significance and plotted as means ± standard error of
mean (SEM). Post-hoc analysis was performed when group differences were
significant by ANOVA at p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include ten figures and can be found with this article online
at http://www.cell.com/supplemental/S0092-8674(09)00447-4.
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